Clinical trials recruiting for Erdheim-Chester Disease
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cobimetinib | 2 |
| Dabrafenib | 1 |
| Trametinib | 1 |
| Vemurafenib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alabama | 1 |
| Arizona | 1 |
| Arkansas | 1 |
| California | 1 |
| District of Columbia | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| New York | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Wisconsin | 1 |
Top cities
Self-screener
Recruiting trials
- Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
- DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
- Histiocytic Disorder Follow-up Study
Related conditions
Trials recruiting for Erdheim-Chester Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Erdheim-Chester Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.